Preliminary results of the treatment of 44 patients with localized prostatic cancer by transrectal focused ultrasound;Résultats préliminaires du traitement de 44 patients porteurs de cancers localisés de la prostate par ultrasons focalisés transrectaux

Progres en Urologie

Volumn 8, Issue 1, 1998, Pages 68-77

  Gelet, Albert ^a   Chapelon, Jean Yves ^b   Bouvier, Raymonde ^a   Pangaud, Catherine ^a   Souchon, Rémi ^b   Blanc, Emmanuel ^c   Cathignol, Dominique ^b   Dubernard, Jean Michel ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b INSERM   (France)

^c Edap Technomed   (France)

Author keywords

Focused ultrasound; Prostatic cancer; Transrectal ultrasonography

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGED; ARTICLE; BLADDER; BURN; CANCER STAGING; DRUG CONTRAINDICATION; EQUIPMENT; EVALUATION; FEVER; FOLLOW UP; HUMAN; INJURY; INSTRUMENTATION; MALE; METHODOLOGY; MINIMAL RESIDUAL DISEASE; ORGAN SIZE; PATHOLOGY; PROSTATE; PROSTATE TUMOR; PROSTATECTOMY; RECTUM; RECTUM FISTULA; REMISSION; SCLEROSIS; SPINAL ANESTHESIA; STRESS INCONTINENCE; TREATMENT FAILURE; ULTRASOUND THERAPY; URETHRA DISEASE; URINARY TRACT FISTULA; URINARY TRACT INFECTION; URINE INCONTINENCE; URINE RETENTION;

ADENOCARCINOMA; AGED; ANESTHESIA, SPINAL; ANTINEOPLASTIC AGENTS, HORMONAL; BURNS; CHEMOTHERAPY, ADJUVANT; EQUIPMENT SAFETY; EVALUATION STUDIES; FEVER; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; NEOPLASM, RESIDUAL; ORGAN SIZE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RECTAL FISTULA; RECTUM; REMISSION INDUCTION; SCLEROSIS; TREATMENT FAILURE; ULTRASONIC THERAPY; URETHRAL DISEASES; URINARY BLADDER; URINARY FISTULA; URINARY INCONTINENCE; URINARY INCONTINENCE, STRESS; URINARY RETENTION; URINARY TRACT INFECTIONS;

EID: 0031992519     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. AUS G., HUGOSSON J., NORLEN L. Long term survival and mortality in prostate cancer treated with non curative intent. J. Urol., 1995, 154, 460-465
2. CHAPELON J Y., MARGONARI J., TEILLERE Y., GORRY F., VERNIER F., BLANC D., GELET A. Effects of high energy focused ultrasound on kidney tissue in the rat and the dog. Eur. Urol., 1992, 21, 147-152.
3. CHAPELON J Y , MARGONARI J , VERNIER F., GORRY F , ECOCHARD R., GELET A In vivo effects of high intensity ultrasound on prostatic adenocarcinoma Dunning R3327. Cancer Res , 1992, 52, 6353-6357.
4. COOGAN C.L., Mc KIEL C. Percutaneous cryoablation of the prostate preliminary results after 95 procedures. J. Urol., 1995, 154, 1813-1817.
5. COX R.L , CRAWFORD G.D. Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate. Urology, 1995, 6, 932-935.
6. FRY W.J., BARNARD J.W , FRY F.V., KRUNINS R.F., BRENNAN J.F. Ultrasonic lesions in mammalian central nervous system Science, 1955, 122, 517-518.
7. GELET A., CHAPELON J Y., BOUVIER R , SOUCHON R., PANGAUD C , ABDELBRAHIM A.F., CATHIGNOL D., DUBERNARD J.M. Treatment of prostate cancer with transrectal focused ultrasound : early clinical experience. Eur. Urol., 1996, 29, 174-183.
8. GELET A., CHAPELON J.Y., MARGONARI J., THEILLERE Y., GORRY F , CATHIGNOL D., BLANC E. Prostatic tissue destruction by high intensity focused ultrasound : experimentation on canine prostate. Endourology, 1993, 7, 249-253.
9. GELET A., CHAPELON J.Y., MARGONARI J., THEILLERE Y., GORRY F., SOUCHON R., BOUVIER R. High intensity focused ultrasound : experimentation on human benign prostatic hypertrophy. Eur. Urol., 1993, 23 (suppl. 1), 44-47.
10. HUGOSSON J., AUS G., NORLEN L. Surveillance is not a viable and appropriate treatment option in the management of localized prostate cancer. Urol. Clin. N. Am., 1996, 557-560.
11. MILLER G.J., CYGAN J.M. Morphology of prostate cancer . the effects of multifocality on histological grade tumor volume and capsule penetration. J. Urol., 1994, 152, 1709-1713.
12. OO STERHOF G.O.N., CORNEL E.B., SMITH G.A H.J., DEBRUYNE F.M.J., SCHALKEN J A. Influence of high intensity focused ultrasound on the development of metastasis. Eur. Urol., 1997, 32, 91-95.
13. PISTERS L.L., VON ESCHENBACH A.C., SCOTT S.M., SWANSON D.A., DINNEY C.P.N., PETTAWAY C.A., BABAIAN R.J. The efficacy and complications of salvage cryotherapy of the prostate. J. Urol., 1997, 157, 921-925.
14. POLLAK A., ZAGAR C.K. Serum prostatic-specific antigen levels three months after radiotherapy for prostate cancer (abst.). J. Urol., 1993, 149, 395A.
15. STAMEY T.A., FERRARI M.K., SCHMID H P. The value of serial prostate-specific antigen determinations 5 years after radiotherapy : steeply increasing values characterize 80% of patients. J. Urol., 1993, 150, 1855-1856.
16. YANG R , REILLY C.R., RESCORLA F.J., FAUGHT R R., SANGHVI N.T., FRY F.J., FRANKLIN R.D., LUMENG L., GROSFELD J.L. High intensity focused ultrasound in the treatment of experimental liver cancer. Arch. Surg., 1991, 126, 1002-1010.
17. ZAGARS G.K. Serum PSA as a tumor marker for patients undergoing definitive radiation therapy Urol. Clin. North Am., 1993, 20, 737-745.
18. ZAGARS G.K., VON ESCHENBACH A.C. Prostate specific antigen : an important marker for prostate cancer treated by external beam radiotherapy. Cancer, 1993, 72, 538-541.
19. ZAGARS G.K. Prostate-specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy. J. Urol., 1994, 152, 1786-1791.